TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment

Alzheimer disease (AD) is a devastating neurodegenerative disorder characterized by extracellular accumulation of amyloid-beta and formation of intracellular neurofibrillary tangles. Microglia activation and neuroinflammation play important roles in the pathogenesis of AD; Toll-like receptor 4 (TLR4...

Full description

Bibliographic Details
Main Authors:	Yongji Zhou, Yanxing Chen, Congcong Xu, Hao Zhang, Caixiu Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Neuroscience
Subjects:	Alzheimer’s disease toll-like receptor 4 neuroinflammation microglia therapeutic target
Online Access:	https://www.frontiersin.org/articles/10.3389/fnins.2020.602508/full

Similar Items

A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer’s Disease
by: Fatima El Idrissi, et al.
Published: (2021-07-01)

Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer’s Disease
by: Weigang Cui, et al.
Published: (2020-05-01)

pKr-2 induces neurodegeneration via upregulation of microglial TLR4 in the hippocampus of AD brain
by: Sehwan Kim, et al.
Published: (2023-03-01)

Identification of Biomarkers Related to M2 Macrophage Infiltration in Alzheimer’s Disease
by: Caixiu Lin, et al.
Published: (2022-08-01)

TLR4 inhibitor TAK-242 attenuates the adverse neural effects of diet-induced obesity
by: V. Alexandra Moser, et al.
Published: (2018-11-01)

miR-154-5p Is a Novel Endogenous Ligand for TLR7 Inducing Microglial Activation and Neuronal Injury
by: Hugo McGurran, et al.
Published: (2024-02-01)

Dexmedetomidine inhibits the lipopolysaccharide‐stimulated inflammatory response in microglia through the pathway involving TLR4 and NF‐κB
by: Xue‐Yue Zhou, et al.
Published: (2019-12-01)

ATP128 Clinical Therapeutic Cancer Vaccine Activates NF-κB and IRF3 Pathways through TLR4 and TLR2 in Human Monocytes and Dendritic Cells
by: Roberta Pascolutti, et al.
Published: (2022-10-01)

Mechanisms and Therapeutic Strategies for MAFLD Targeting TLR4 Signaling Pathways
by: Guanghui Ren, et al.
Published: (2023-12-01)

Alginate-Derived Oligosaccharide Inhibits Neuroinflammation and Promotes Microglial Phagocytosis of β-Amyloid
by: Rui Zhou, et al.
Published: (2015-09-01)

Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie
by: Mirta García-Martínez, et al.
Published: (2022-03-01)

The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD miceResearch in context
by: Zhihui Zhu, et al.
Published: (2023-08-01)

Identification and characterization of toll-like receptor (TLR) 2 and 4 mutations in colorectal
by: Davoodi, Homa
Published: (2009)

Role of Microglia TLRs in Neurodegeneration
by: Bernd L. Fiebich, et al.
Published: (2018-10-01)

Primary Cortical Cell Tri-Culture-Based Screening of Neuroinflammatory Response in Toll-like Receptor Activation
by: Noah Goshi, et al.
Published: (2022-08-01)

Inflammation, microglia, and alzheimer's disease
by: Brent Cameron, et al.
Published: (2010-03-01)

Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
by: Anna Skrzypczak-Wiercioch, et al.
Published: (2022-08-01)

The effect of intranasally administered TLR3 agonist larifan on metabolic profile of microglial cells in rat with C6 glioma
by: Y. Hurmach, et al.
Published: (2018-11-01)

TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
by: Yueran Li, et al.
Published: (2023-09-01)

Prognostic and clinicopathological significance of TLR4 expression in patients with breast cancer: a meta-analysis
by: Jinxu Wen, et al.
Published: (2024-02-01)

Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia
by: Xue Wang, et al.
Published: (2022-08-01)

Glyphosate as a direct or indirect activator of pro-inflammatory signaling and cognitive impairment
by: Yukitoshi Izumi, et al.
Published: (2024-01-01)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
by: Guimei Zhang, et al.
Published: (2021-11-01)

TLR‐2 and TLR‐4 expression in monocytes of newborns with late‐onset sepsis
by: Ana C.C. Redondo, et al.
Published: (2014-09-01)

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target
by: Qinqin Wang, et al.
Published: (2021-11-01)

Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli MR, et al.
Published: (2016-11-01)

The expression of TLR2 and TLR4 in the kidneys and heart of mice infected with Acanthamoeba spp.
by: Karolina Kot, et al.
Published: (2020-09-01)

Coactivation of TLR2 and TLR8 in Primary Human Monocytes Triggers a Distinct Inflammatory Signaling Response
by: Korbinian Bösl, et al.
Published: (2018-05-01)

Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 signaling pathway
by: Wenfeng Liu, et al.
Published: (2019-04-01)

Critical Role of TLR4 on the Microglia Activation Induced by Maternal LPS Exposure Leading to ASD-Like Behavior of Offspring
by: Lu Xiao, et al.
Published: (2021-03-01)

Decreased Toll-like Receptor (TLR) 2 and 4 Expression in Spermatozoa in Couples with Unexplained Recurrent Spontaneous Abortion (URSA)
by: Nasrin Sereshki, et al.
Published: (2019-11-01)

TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies
by: Rebecca Heinz, et al.
Published: (2022-10-01)

Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling
by: Hongyuan Li, et al.
Published: (2021-05-01)

TLR-2 and TLR-4 expression in monocytes of newborns with late-onset sepsis,
by: Ana C.C. Redondo, et al.
Published: (2014-10-01)

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
by: Nour F. Al-Ghraiybah, et al.
Published: (2022-09-01)

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
by: Nour S. Tobeh, et al.
Published: (2023-10-01)

Curcumin Mitigates Neuro-Inflammation by Modulating Microglia Polarization Through Inhibiting TLR4 Axis Signaling Pathway Following Experimental Subarachnoid Hemorrhage
by: YongYue Gao, et al.
Published: (2019-11-01)

Anti-TLR2 antibody triggers oxidative phosphorylation in microglia and increases phagocytosis of β-amyloid
by: Ana Rubio-Araiz, et al.
Published: (2018-08-01)

Microglia and Alzheimer’s Disease
by: Stefania Merighi, et al.
Published: (2022-10-01)

The Effect of C-Phycocyanin on Microglia Activation Is Mediated by Toll-like Receptor 4
by: Anna Piovan, et al.
Published: (2022-01-01)